NHS Approves Two Medicines Derived From Cannabis in England
This week, the NHS approved two cannabis-derived medicines for the first time. It is a positive step for the future of legal cannabis in England.
Read More
United Kingdom Studies CBD in Treating Children’s Brain Tumors
Researchers in the United Kingdom will be studying the effects of medical cannabis on children with brain tumors in a first of its kind study.
Read More
The British Government Is Backing CBD
UK Medicines and Healthcare Products Regulatory Agency Approves CBD The British government on Tuesday…
Read More
Top UK Officials: UN-inspired War on Drugs Failed
By Alex Newman | Â Published in The New American On the 50th anniversary of…
Read More
GW Announces UK Launch of World’s First Prescription Cannabis Medicine
Sativex®, available as a prescription only medicine, was developed by GW in specific response to calls from people with MS for a prescription cannabis-based medicine. Today’s launch means that MS patients suffering the spasms and cramping associated with spasticity have access to a new treatment option which has been shown to improve their symptoms where current treatments have failed.
Sativex® is manufactured by GW under Home Office licence at an undisclosed location in the UK. The medicine is being marketed in the UK by GW’s UK licensee, Bayer Schering Pharma.
Read More